Empowered Funds
XGN icon

Empowered Funds’s Exagen XGN Stock Holding History

Empowered Funds’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$198K Buy
+24,396
New +$157K ﹤0.01% 2261

Other funds holding XGN

Wexford Capital
Wexford Capital West Palm Beach, Florida $763M AUM 59.25% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $140M AUM 44.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
MBAM
Mink Brook Asset Management West Palm Beach, Florida $212M AUM 53.36% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
F.L. Putnam Investment Management
F.L. Putnam Investment Management Lynnfield, Massachusetts $9.33B AUM 30.52% 1-Year Est. Return
Kennedy Capital Management
Kennedy Capital Management St Louis, Missouri $5.31B AUM 40.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Empowered Funds's XGN Position: Q3 2026 in Review

Empowered Funds opened a new position in Exagen (XGN) in Q3 2026: 24,396 shares worth $198K. The stake represents ﹤0.01% of the portfolio and ranks #2261 among its holdings.

48 funds tracked by Wall St. Rank hold XGN as of Q3 2026.

  • Empowered Funds held 24,396 shares of Exagen worth $198K as of Q3 2026.
  • Exagen was a new Empowered Funds position in Q3 2026.
  • Exagen made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2261 holding.
  • 48 funds tracked by Wall St. Rank held Exagen as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.